Search Clinical Trials in the EU

6-12 months

Visits

Phase

Intake methods

Benefits

Drugs

Locations

Clinical Specialty

381-397 of 397 trials

Deuruxolitinib: Safety Study in Healthy Adults

We are testing a new medication to see how safe it is and how the body reacts to it in healthy adults. This study helps us understand its potential for future treatments.

Alopecia Areata6-12 monthsSafety phase (I)AllergologyInfectious DiseasesRheumatology

RO7504109: Immune Cell Study

We are investigating how the new treatment RO7504109 affects immune cells in healthy individuals. This research may help us learn more about its potential uses in the future.

Healthy Participants6-12 monthsSafety phase (I)AllergologyDermatologyInternal MedicineOphthalmologyOtolaryngologyPediatricsPsychiatry

Cabergoline for Episodic Migraine Relief

We are studying whether cabergoline can help reduce the frequency and severity of migraines in people with episodic migraine. Participants will receive either cabergoline or a placebo to compare effects.

Episodic Migraine6-12 monthsConfirmation phase (III)≤5 visits Post-Trial Drug Access Standard Medicines Partially RemoteNeurology

Survodutide: Comparing Two Formulations

We are studying how two different formulations of survodutide are absorbed by healthy people. This research may help improve future treatments using this medication.

Healthy Volunteers6-12 monthsSafety phase (I)

Psoriasis Treatment: CKD-704 vs. Skyrizi®

We are comparing a new biosimilar treatment for psoriasis with the approved Skyrizi® to see how safe it is and how well it works in healthy adults.

Moderately to Severely Active Crohn’s DiseaseModerate-to-Severe Plaque PsoriasisActive Psoriatic Arthritis6-12 monthsSafety phase (I)DermatologyGastroenterologyInfectious DiseasesRheumatology

Alzheimer’s Disease: MTX46943 Study

We are investigating a new compound to see if it is safe and effective for treating Alzheimer’s disease and other neurological disorders. This study looks at how the drug is absorbed and processed in the body.

Alzheimer's Disease6-12 monthsSafety phase (I)Internal MedicineNeurology

Pain Measurement: Nefopam and Oxycodone Study

We are exploring new test methods to measure pain in individuals using nefopam and oxycodone. This research aims to improve how we assess pain relief with these medications.

Chronic Pain6-12 monthsSafety phase (I)Internal MedicineNeurology

Psoriasis: Investigational Skin Products

We are assessing the safety and effects of new products on skin affected by psoriasis. This study aims to understand how these products may help improve skin health.

Plaque Psoriasis6-12 monthsSafety phase (I)AllergologyDermatology

Kidney Protection: Semaglutide and Finerenone in CKD

We are studying how semaglutide and finerenone may help protect the kidneys in people with chronic kidney disease. This includes patients with and without diabetes to explore their effects and mechanisms.

Chronic Kidney Disease6-12 monthsMonitoring phase (IV)≤5 visits No Placebo Investigational Medicines Cost Reimbursement Partially RemoteEndocrinologyNephrology

Rheumatoid Arthritis: Methotrexate and Novobiocin Study

We are investigating how a combination of Methotrexate and Novobiocin affects patients with rheumatoid arthritis. This study aims to learn more about the treatment's effectiveness and safety.

Rheumatoid Arthritis6-12 monthsSafety phase (I)Rheumatology

Comparing PB016 to Entyvio for Healthy Participants

We are studying a new treatment to see how it works and its safety compared to an established medication. This trial involves healthy individuals to help us understand the differences between the two.

Healthy Participants6-12 monthsSafety phase (I)GastroenterologyInternal Medicine

Prazosin Absorption Study in Healthy Adults

We are investigating how different forms of Prazosin are absorbed into the blood in healthy adults. This research may help improve how this medication is used in future treatments.

High Blood Pressure and Heart Failure6-12 monthsSafety phase (I)CardiologyInternal Medicine

Influenza Vaccine Study for Adults

We are assessing a new mRNA-based vaccine to see how well it boosts the immune response and its safety in adults aged 18 and older. This study aims to improve protection against seasonal influenza.

Human Influenza6-12 monthsEfficacy phase (II)≤5 visits Post-Trial Drug Access No Placebo Investigational Medicines Cost ReimbursementInfectious Diseases

MSP-2020: Effects on Brain Activity in Healthy Adults

We are examining how MSP-2020 affects brain activity in healthy adults. This study aims to understand its potential impact on cognitive functions.

Major Depressive Disorder6-12 monthsSafety phase (I)Psychiatry

Safety Study of AX-5006 in Parkinson's Disease

We are investigating the safety of a new treatment called AX-5006 for people with and without Parkinson's disease. This research aims to understand how the agent affects different individuals.

Parkinson's Disease6-12 monthsSafety phase (I)Neurology

ARV-102: Food and Esomeprazole Interaction Study

We are investigating how food and a common heartburn medication affect the way a new drug is absorbed in healthy individuals. This research may help improve future treatments.